During this webinar, you will:
- Learn about the importance of genetics and laboratory services in medication management
- Be able to describe molecular genetic assay requirements for pharmacogenomics (PGx) testing
- Understand the stages of PGx testing implementation as it relates to individual laboratory maturity
- Learn the strategic actions to take to expand into pharmacogenomics
- Be able to define which stage your laboratory is currently in and assess for potential expansion
About this webinar
Pharmacogenomics (PGx) has immense potential in the routine clinical testing space. However, there are many considerations to PGx adoption and scalability within the laboratory. Clinical laboratory leaders are unaware of their laboratory’s readiness, the stages of PGx implementation maturity, and the strategic steps they should take to expand into PGx.
In this Dark Daily webinar with live Q&A, Jeff Shaman, PhD, MS, Chief Science Officer of Coriell Life Sciences will discuss why pharmacogenomics matters and how the COVID health crisis has created unprecedented capacity and acceptance for PGx in laboratory testing.
Up-and-coming and seasoned lab leaders will learn how laboratory technology, science, implementation models, and economic proof points have all achieved deployable maturity for PGx labs. Most importantly, we will define the stages of PGx laboratory implementation maturity and key success points for expanding your laboratory’s PGx testing capacity.
Jeff Shaman, PhD, MS
Chief Science Officer
Coriell Life Sciences
Jeffrey A. Shaman, PhD, MS, is the Chief Science Officer at Coriell Life Sciences (CLS). Leveraging extensive experience in genetics and pharmacology, Shaman is an expert in the rapidly evolving field of pharmacogenomics (PGx). He plays a critical role in bridging the gap between genetic science and clinical application and is an active member of the Clinical Pharmacogenetics Implementation Consortium (CPIC), Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community, Personalized Medicine Coalition (PMC), Pharmacogenomics Global Research Network (PGRN), and other organizations.
Shaman holds a doctoral degree from The Johns Hopkins University School of Medicine in Pharmacology and Molecular Sciences, where his research centered on DNA, epigenetics, and nuclear structure and function. He earned his Master of Science degree from The University of Medicine and Dentistry of New Jersey in Cell and Developmental Biology. Shaman held a faculty position at the University of Hawai‘i Institute of Biogenesis Research before serving a fellowship at Harvard Medical School and implementing a translational research program at Beth Israel Deaconess Medical Center and the Bedford Stem Cell Research Foundation.
Who should attend?
- Clinical laboratory directors
- Laboratory managers
- Clinical pathologists
- Healthcare executives
- Academic medical centers
- Public health laboratories
- Laboratory technicians
- Anyone involved in clinical laboratory testing